Argenx (ARGX) has released an update.
Argenx SE, a global immunology company, has announced its Annual General Meeting for shareholders on May 7, 2024, at the Hilton Amsterdam Schiphol. The meeting will cover key agenda items including the adoption of the 2023 annual accounts, potential board director appointments, and auditor selections for the upcoming financial years. Shareholders are encouraged to vote electronically and can access meeting materials and the annual report on the Argenx website.
For further insights into ARGX stock, check out TipRanks’ Stock Analysis page.
